IDXX Q2 2024 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q2 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.0B+6.4% YoY

Gross Profit

$621M61.9% margin

Operating Income

$264M26.3% margin

Net Income

$203M20.3% margin

EPS (Diluted)

$2.44

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$248M

Free Cash Flow

$215M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$1.8B

Stockholders' Equity

$1.6B

Cash & Equivalents

$402M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$944M	+6.4%
Gross Profit	$621M	$573M	+8.4%
Operating Income	$264M	$296M	-10.9%
Net Income	$203M	$224M	-9.3%

Revenue Segments

Product

$577M58%

Service

$426M42%

Geographic Segments

UNITED STATES

$660M66%

EMEA

$201M20%

Asia Pacific

$80M8%

CANADA

$41M4%

Latin America

$21M2%